Anti-biofilm and anti-virulence activity of a rare actinobacteria Nocardia sp. EMB45 against Pseudomonas aeruginosa
Archives of Microbiology · 2026
DOI: 10.1007/s00203-026-04715-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Saniya Zaidi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Enzyme and Microbial Biochemistry Laboratory, Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India. Hauptthemen laut MEDLINE: Biofilms, Nocardia, Pseudomonas aeruginosa, Anti-Bacterial Agents. Die Arbeit nennt 63 Literaturangaben.
Abstract (Originalsprache)
Pseudomonas aeruginosa forms resilient, antibiotic-tolerant biofilms, with quorum sensing (QS) as a central regulator of biofilm formation and virulence. In this study, we report Nocardia sp. EMB45, isolated from termite nest soil, as a novel source of antibiofilm metabolites. The crude extract inhibited P. aeruginosa PAO1 biofilm formation with a minimum biofilm inhibitory concentration (MBIC) of 6 mg/mL. Morphological analyses by FE-SEM and AFM revealed disrupted biofilm architecture, while confocal microscopy showed sparse and less dense biofilms composed predominantly of viable cells. Mechanistic studies demonstrated QS inhibition using the biosensor Chromobacterium violaceum CV026, suggesting interference with AHL-mediated signalling. The extract markedly reduced QS-regulated phenotypes, including exopolysaccharide production and virulence factors. qRT-PCR analysis demonstrated strong suppression of QS genes, with lasI, lasR, rhlI, and rhlR showing ~ 14- to 20-fold downregulation relative to untreated controls. GC–MS analysis identified 22 metabolites, among which compound C1 (1,2-oxathiane,6-dodecyl-,2,2-dioxide) and compound C4 (Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)-) exhibited the highest binding affinities toward LasR and RhlR, respectively, in molecular docking and dynamics simulations. These findings highlight Nocardia sp. EMB45 is a promising and underexplored source of antibiofilm metabolites with potential applications in anti-virulence therapy against P. aeruginosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Enzyme and Microbial Biochemistry Laboratory, Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India.
- Institute for Lasers, Photonics and Biophotonics, Department of Chemistry, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
- Transcription Regulation Lab, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad, 121001, India.
- Department of Microbiology, All India Institute of Medical Sciences, New Delhi, 110029, India.
- Enzyme and Microbial Biochemistry Laboratory, Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India. skkhare@chemistry.iitd.ac.in.
- Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, 741246, India. skkhare@chemistry.iitd.ac.in.
Zitieren
APA
Zaidi, S., Srivastava, N., Ghosh, M., Jain, D., Prasad, P. N., Sood, S., & Khare, S. K. (2026). Anti-biofilm and anti-virulence activity of a rare actinobacteria Nocardia sp. EMB45 against Pseudomonas aeruginosa. Archives of Microbiology. https://doi.org/10.1007/s00203-026-04715-x
Vancouver
Zaidi S, Srivastava N, Ghosh M, Jain D, Prasad PN, Sood S, et al. Anti-biofilm and anti-virulence activity of a rare actinobacteria Nocardia sp. EMB45 against Pseudomonas aeruginosa. Archives of Microbiology. 2026. doi:10.1007/s00203-026-04715-x
BibTeX
@article{Zaidi2026,
author = {Zaidi, Saniya and Srivastava, Nitin and Ghosh, Moumita and Jain, Deepti and Prasad, Paras N and Sood, Seema and Khare, Sunil Kumar},
title = {Anti-biofilm and anti-virulence activity of a rare actinobacteria Nocardia sp. EMB45 against Pseudomonas aeruginosa},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-026-04715-x}
}
EUVIMED